David N Potter1, Diane Damez-Werno2, William A Carlezon1, Bruce M Cohen2, Elena H Chartoff3. 1. Behavioral Genetics Laboratory, Harvard Medical School, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts. 2. Molecular Pharmacology Laboratory, Harvard Medical School, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts. 3. Behavioral Genetics Laboratory, Harvard Medical School, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts. Electronic address: echartoff@mclean.harvard.edu.
Abstract
BACKGROUND: Repeated exposure to drugs of abuse and stress increase dynorphin, a κ opioid receptor (KOR) ligand, in the nucleus accumbens (NAc). Acute KOR activation produces dysphoria that might contribute to addictive behavior. How repeated KOR activation modulates reward circuitry is not understood. METHODS: We used intracranial self-stimulation (ICSS), a method that provides a behavioral index of reward sensitivity, to measure the effects of repeated administration of the KOR agonist salvinorin A (salvA) (2 mg/kg) on the reward-potentiating effects of cocaine (5.0 mg/kg). In separate rats, we measured the effects of salvA on activation of extracellular signal regulated kinase (ERK), cyclic adenosine monophosphate (cAMP) response element binding protein, and c-Fos within the NAc. RESULTS: SalvA had biphasic effects on reward: an immediate effect was to decrease the rewarding impact of ICSS, whereas a delayed effect was to increase the rewarding impact of ICSS. Repeated salvA produced a net decrease in the reward-potentiating effects of cocaine. In the NAc, both acute and repeated salvA administration increased phosphorylated ERK, whereas only acute salvA increased c-Fos and repeated salvA increased phosphorylated cAMP response element binding protein. The KOR antagonist nor-binaltorphimine (20 mg/kg) blocked the immediate and delayed effects of salvA and prolonged the duration of cocaine effects in ICSS. CONCLUSIONS: Repeated salvA might trigger opponent processes such that "withdrawal" from the dysphoric effects of KOR activation is rewarding and decreases the net rewarding valence of cocaine. The temporal effects of salvA on ERK signaling suggest KOR-mediated engagement of distinct signaling pathways within the NAc that might contribute to biphasic effects on reward sensitivity.
BACKGROUND: Repeated exposure to drugs of abuse and stress increase dynorphin, a κ opioid receptor (KOR) ligand, in the nucleus accumbens (NAc). Acute KOR activation produces dysphoria that might contribute to addictive behavior. How repeated KOR activation modulates reward circuitry is not understood. METHODS: We used intracranial self-stimulation (ICSS), a method that provides a behavioral index of reward sensitivity, to measure the effects of repeated administration of the KOR agonist salvinorin A (salvA) (2 mg/kg) on the reward-potentiating effects of cocaine (5.0 mg/kg). In separate rats, we measured the effects of salvA on activation of extracellular signal regulated kinase (ERK), cyclic adenosine monophosphate (cAMP) response element binding protein, and c-Fos within the NAc. RESULTS:SalvA had biphasic effects on reward: an immediate effect was to decrease the rewarding impact of ICSS, whereas a delayed effect was to increase the rewarding impact of ICSS. Repeated salvA produced a net decrease in the reward-potentiating effects of cocaine. In the NAc, both acute and repeated salvA administration increased phosphorylated ERK, whereas only acute salvA increased c-Fos and repeated salvA increased phosphorylated cAMP response element binding protein. The KOR antagonist nor-binaltorphimine (20 mg/kg) blocked the immediate and delayed effects of salvA and prolonged the duration of cocaine effects in ICSS. CONCLUSIONS: Repeated salvA might trigger opponent processes such that "withdrawal" from the dysphoric effects of KOR activation is rewarding and decreases the net rewarding valence of cocaine. The temporal effects of salvA on ERK signaling suggest KOR-mediated engagement of distinct signaling pathways within the NAc that might contribute to biphasic effects on reward sensitivity.
Authors: John W Muschamp; Ashlee Van't Veer; Aram Parsegian; Miranda S Gallo; Melissa Chen; Rachael L Neve; Edward G Meloni; William A Carlezon Journal: J Neurosci Date: 2011-02-23 Impact factor: 6.167
Authors: Stephanie R Ebner; Mitchell F Roitman; David N Potter; Anna B Rachlin; Elena H Chartoff Journal: Psychopharmacology (Berl) Date: 2010-04-07 Impact factor: 4.530
Authors: Jonathan A Hollander; Heh-In Im; Antonio L Amelio; Jannet Kocerha; Purva Bali; Qun Lu; David Willoughby; Claes Wahlestedt; Michael D Conkright; Paul J Kenny Journal: Nature Date: 2010-07-08 Impact factor: 49.962
Authors: Benjamin B Land; Michael R Bruchas; Selena Schattauer; William J Giardino; Megumi Aita; Daniel Messinger; Thomas S Hnasko; Richard D Palmiter; Charles Chavkin Journal: Proc Natl Acad Sci U S A Date: 2009-10-28 Impact factor: 11.205
Authors: Hilarie C Tomasiewicz; Mark S Todtenkopf; Elena H Chartoff; Bruce M Cohen; William A Carlezon Journal: Biol Psychiatry Date: 2008-07-17 Impact factor: 13.382
Authors: Elena H Chartoff; David Potter; Diane Damez-Werno; Bruce M Cohen; William A Carlezon Journal: Neuropsychopharmacology Date: 2008-01-09 Impact factor: 7.853
Authors: Elena Chartoff; Allison Sawyer; Anna Rachlin; Dave Potter; Andrea Pliakas; William A Carlezon Journal: Neuropharmacology Date: 2011-06-29 Impact factor: 5.250
Authors: Cindee F Robles; Marissa Z McMackin; Katharine L Campi; Ian E Doig; Elizabeth Y Takahashi; Michael C Pride; Brian C Trainor Journal: Behav Brain Res Date: 2014-01-18 Impact factor: 3.332
Authors: Timothy W Whitfield; Joel E Schlosburg; Sunmee Wee; Adam Gould; Olivier George; Yanabel Grant; Eva R Zamora-Martinez; Scott Edwards; Elena Crawford; Leandro F Vendruscolo; George F Koob Journal: J Neurosci Date: 2015-03-11 Impact factor: 6.167
Authors: Cullen L Schmid; John M Streicher; Chad E Groer; Thomas A Munro; Lei Zhou; Laura M Bohn Journal: J Biol Chem Date: 2013-06-17 Impact factor: 5.157